In a retrospective study of limited-disease small-cell lung cancer patients undergoing thoracic chemoradiotherapy, patients with a high CRP level showed longer OS than those with lower CRP level (median 20 vs. 14 months, respectively, p = 0.025) [129]. This evidence concerns the gene CRP and glycogen storage disease VI.